• 1
    Kelly DA, Tuddenham EGD. Hemostatic problems in liver disease. Gut 1986; 27: 339349.
  • 2
    Blake JC, Sprengers D, Grech P, McCormick PA, McLntyre N, Burroughs AK. Bleeding time in patients with hepatic cirrhosis. Br Med J 1990; 301: 1215.
  • 3
    Mammen EF. Coagulation abnormalities in liver disease. Hematol Oncol Clin North Am 1992; 6: 12471257.
  • 4
    Ferro D, Quintarelli C, Saliola M, Alessandri C, Basili S, Bonavita MS, Violi F. Prevalence of hyperfibrinolysis in patients with liver cirrhosis. Fibrinolysis 1992; 6: 14.
  • 5
    Violi F, Ferro D, Basili S, Quintarelli C, Saliola M, Alessandri C, Cordova C, et al. Hyperfibrinolysis increase the risk of gastrointestinal haemorrhage in patients with advanced liver cirrhosis. Hepatology 1992; 15: 672676.
  • 6
    Stein SF, Harker LA. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 1982; 99: 217230.
  • 7
    Violi F, Leo R, Davi G, Pratico D, Luliano L, Balsano F. Thrombocytopenia and thrombocytopathia in liver cirrhosis. Platelets 1992; 3: 233239.
  • 8
    Thomas DP, Ream VJ, Stuart RK. Platelet aggregation in patients with Laennec's cirrhosis of the liver. N Engl J Med 1967; 276: 13441348.
  • 9
    Ballard HS, Marcus AJ. Platelet aggregation in portal cirrhosis. Arch Intern Med 1976; 136: 316319.
  • 10
    Rubin MH, Weston MJ, Langley PG, White Y, Williams R. Platelet function in chronic liver disease. Relationship to disease severity. Dig Dis Sci 1979; 24: 197202.
  • 11
    Laffi G, Lavilla G, Pinzani M, Ciabattoni G, Patrignani P, Mannelli M, Cominelli F, et al. Altered renal and platelet arachidonic acid metabolism. Gastroenterology 1986; 90: 274282.
  • 12
    Laffi G, Cominelli F, Ruggiero M, Fedi S, Chiarugi VP, Lavilla G, Pinzani M, et al. Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonate acid metabolism in response to agonists. Hepatology 1988; 8: 16201626.
  • 13
    Laffi G, Daskalopolulos G, Kronborg I, Hsueh W, Genticini P, Zipser RD. Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. Gastroenterology 1986; 90: 182187.
  • 14
    Laffi G, Marra F, Failli P, Ruggiero M, Cecchi E, Carloni V, Giotti A, et al. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology 1993; 105: 148156.
  • 15
    Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, et al. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992; 103: 641646.
  • 16
    Ordinas A, Maragall S, Castillo R, Nurden AT. A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver. Thromb Res 1978; 13: 297302.
  • 17
    Francis JL, Armstrong DJ. Acquired dysfibrinogenemia in liver disease. J Clin Pathol 1982; 35: 667672.
  • 18
    Desai K, Bagget C, Bellamy MF, Mistry P, Burroughs AK, Owen JS. Inhibition of platelet aggregation by abnormal high density lipoprotein in plasma from patients with hepatic cirrhosis. Lancet 1989; 1: 693695.
  • 19
    Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973; 5: 167179.
  • 20
    Bolhuis PA, Sakariassen KS, Sander HJ, Bouma BN, Sixma JJ. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med 1981; 97: 568576.
  • 21
    Sakariassen KS, Bolhuis PA, Blomback M, Thorell L, Blomback B, Sixma JJ. Association between bleeding time and platelet adherence to artery subendothelium. Thromb Haemost 1984; 52: 144147.
  • 22
    Sakariassen KS, Nieuwenhuis HK, Sixma JJ. Differentiation of patients with subtype lib-like von Willebrand's disease by means of perfusion experiments with reconstituted blood. Br J Haematol 1985; 59: 459470.
  • 23
    Sakariassen KS, Nievelstein PF, Coller BS, Sixma JJ. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681691.
  • 24
    Sakariassen KS, Cattaneo M, v d Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984; 64: 229236.
  • 25
    Escolar G, Mazzara R, White JG, Castillo R, Ordinas A. Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of platelet concentrates. Blood Cells 1992; 18: 403415.
  • 26
    Moia M, Mannucci PM, Vizzotto L, Casati S, Cattaneo M, Ponticelli C. Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 1987; 2: 12271229.
  • 27
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding esopageal varices. Br J Surg 1973; 60: 646649.
  • 28
    Rao GH, Escolar G, White JG. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res 1986; 44: 6574.
  • 29
    Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A. Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 1986; 68: 337342.
  • 30
    Born GVR. The aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927929.
  • 31
    Baumgartner HR. Platelet interaction with collagen fibrils in flowing blood. Reaction of human platelet with α-chymotrypsyin digested subendothelium. Thromb Haemost 1977; 37: 115.
  • 32
    Escolar G, Bastida E, Castillo R, Ordinas A. Development of a computer program to analyze the parameters of platelet-vessel wall interaction. Haemostasis 1986; 16: 814.
  • 33
    Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 1988; 28: 406411.
  • 34
    Livio M, Gotti E, Marchesi D, Remuzzi G, Mecca G, de Gaetano G. Uraemic bleeding: role of anemia and beneficial effect of red cell transfusion. Lancet 1982; 2: 10131015.
  • 35
    Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Sue JM, Boneu B. Low hematocrit and prolonged bleeding time in uraemic patients: Effect of red cell transfusions. Br J Haematol 1985; 59: 139148.
  • 36
    Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: Physical role of red blood cell. Microvasc Res 1975; 9: 335344.
  • 37
    Aarts PA, Bolhuis PA, Sakariassen KS, Heethaar RM, Sixma JJ. Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood 1983; 62: 214217.
  • 38
    Baumgartner HR. Effects of acetylsalicilic acid, sulfinpyrazone and dipyri-damole on platelet adhesion and aggregation in flowing native and anticoagulated blood. Haemostasis 1979; 8: 340352.
  • 39
    Tschopp TB. Aspirin inhibits platelet aggregation on, but not adhesion to, collagen fibrils: and assessment of platelet adhesion and deposited platelet mass by morphometry and 51-Cr-labeling. Thromb Res 1977; 11: 619632.
  • 40
    Weiss HJ, Turitto VT, Vicic WJ, Baumgartner HR. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood. Thromb Haemost 1981; 45: 136141.
  • 41
    Escolar G, Bastida E, Ordinas A, Castillo R. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination. Thromb Res 1985; 40: 419424.
  • 42
    Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986; 67: 322330.
  • 43
    Turitto VT, Weiss HJ, Baumgartner HR. Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment. J Lab Clin Med 1983; 102: 551564.
  • 44
    Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823831.
  • 45
    Sanchez-Roig MJ, Rivera J, Moraleda JM, Vicente García V. Quantitative defect of glycoprotein Ib in severe cirrhotic patients. Am J Hematol 1994; 45: 1015.
  • 46
    Mannucci PM, Vicente V, Vianello L, Cattaneo M, Alberca I, Coccato MP, Faioni E, et al. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 11481153.
  • 47
    Beer JH, Clerici N, Baillod P, von Felten A, Schlappritzi E, Büchi L. Quantiative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis. Thromb Haemost 1995; 73: 601609.
  • 48
    Cruz MA, Handin RI, Wise RJ. The interaction of the von Willebrand factor—A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem 1993; 268: 2123821245.